Rheumatology Research Foundation Lecture: Learning lessons from @Google to harness #omics to better understand #RA #ACR21 @RheumNow @RheumResearch https://t.co/NVAe2Rqo1O

@NamrataRheum on outcomes in RA patients on RTX who get COVID-19. ⬆️hospitalisation, ICU, mech ventilation, but not mortality (in this cohort) Abstr#1445 #ACR21 @RheumNow https://t.co/8RcrzTdEb0

Yup, another large database shows more #hospitalizations with #RheumatoidArthritis with #rituximab but NOT higher mortality in matched analysis. Abst#1445 #ACR21 @RheumNow https://t.co/9XV8iX10sA

You can <but not as frequently> treat to target in #RheumatoidArthritis with virtual v in person visits. 45 docs in 18 practices comparing in person to virtual. In person wins but not by a large gap! Abst#1448 @dansolomon @RheumNow #ACR21 #ACRBest session today coming up https://t.co/8lcuMW0bwb

Does #baricitinib affect #fatigue in RA patients? 👉🏼Results from RA-BEAM and RA-BEACON 👉🏼4mg baricitinib significantly reduced fatigue, starting week 16, compared to placebo 👉🏼Effect independent of disease activity in active RA Abs#1235 #ACR21 @RheumNow https://t.co/0SKhUKJHd7 https://t.co/R76wc56u6I

• Treatment Effect of Baricitinib on Fatigue: Mediation Analysis Results from Two…